Valuation: Dr. Martens plc

Market Cap 649M 859M 754M 712M 1.21B 82.35B 1.22B 8.52B 3.3B 42.07B 3.23B 3.16B 135B P/E 2027 *
13.7x
P/E 2028 * 11x
Enterprise Value 846M 1.12B 982M 928M 1.58B 107B 1.59B 11.1B 4.3B 54.82B 4.2B 4.11B 176B EV / Sales 2027 *
1.08x
EV / Sales 2028 * 0.99x
Free-Float
57.57%
Yield 2027 *
3.68%
Yield 2028 * 3.74%
1 day+0.30%
1 week+0.74%
Current month-12.63%
1 month-13.96%
3 months-5.83%
6 months+8.22%
Current year-11.49%
1 week 65.6
Extreme 65.6
69.6
1 month 62.3
Extreme 62.3
82
Current year 59.15
Extreme 59.15
90
1 year 59.15
Extreme 59.15
100.87
3 years 43.02
Extreme 43.02
148.3
5 years 43.02
Extreme 43.02
448.2
10 years 43.02
Extreme 43.02
521.6
Manager TitleAgeSince
Chief Executive Officer 55 2025-01-05
Director of Finance/CFO 53 2024-05-12
Chief Operating Officer - -
Director TitleAgeSince
Director/Board Member 53 2020-12-31
Director/Board Member 55 2025-07-09
Director/Board Member 52 2020-12-31
Date Insider Type Main position Quantity % Market Cap. Importance
5/29/26 Free

Chief Executive Officer

2,732,653 0.2823%
5/29/26 Free

Chief Financial Officer

2,100,151 0.2170%
5/13/26 Buy

Chief Financial Officer

233 0.0000%
Change 5-day change 1-year change 3-year change Capi.($)
+0.30%+0.74%-25.90%-51.64% 859M
-0.01%+0.31%-25.66%-7.74% 10.71B
+2.19%+3.19%+64.57%+46.15% 6.05B
+5.69%+9.95%-25.18% - 5.98B
+4.14%+5.59%-37.30%-33.07% 5.94B
-0.24%+3.30%-1.65%+35.83% 2.56B
+0.20%+1.01%-13.97%-16.13% 2.31B
+8.10%+7.43%+45.95%+77.04% 1.59B
-1.19%+0.74%-31.67%+124.35% 1.57B
-1.35%-1.68%-31.22% - 1.15B
Average +1.78%+2.70%-8.20%+21.85% 3.87B
Weighted average by Cap. +2.10%+3.41%-8.48%+10.34%

Financials

2027 *2028 *
Net sales 784M 1.04B 910M 860M 1.47B 99.44B 1.48B 10.29B 3.99B 50.8B 3.9B 3.81B 163B 822M 1.09B 955M 902M 1.54B 104B 1.55B 10.79B 4.18B 53.28B 4.09B 4B 171B
Net income 48.53M 64.26M 56.39M 53.26M 90.85M 6.16B 91.5M 637M 247M 3.15B 241M 236M 10.11B 60.18M 79.67M 69.91M 66.03M 113M 7.64B 113M 790M 306M 3.9B 299M 293M 12.54B
Net Debt 197M 260M 229M 216M 368M 24.96B 371M 2.58B 1B 12.75B 978M 957M 40.98B 165M 218M 192M 181M 309M 20.93B 311M 2.17B 839M 10.69B 820M 802M 34.37B
Logo Dr. Martens plc
Dr. Martens plc is a United Kingdom-based company, which designs, develops, procures, markets, sells and distributes footwear, under the Dr. Martens brand. The Company's segments include Europe, the Middle East and Africa (EMEA); Americas; and Asia-Pacific (APAC). Its product segments include boots, shoes, sandals, and bags & other. Its boots offerings include the 1460 8-eye boot, 2976 Chelsea boot, Jadon, Bex and Sinclair. Its shoes offerings include 1461 3-eye shoe and the Adrian tassel loafer, as well as franchises/families such as Buzz and Lowell. Its sandals range includes Blaire and Gryphon silhouettes and also includes the mules range, led by the Zebzag. Its bag range is focused on key silhouettes of leather bags, such as the Kiev backpack, the heart-shaped bag and its weekender bag. This category also includes socks, laces and shoe care. The Company offers its products through direct-to-consumer channel via its ecommerce platforms and its stores, among others.
Employees
2,377
Date Price Change Volume
26-09-25 GBX 67.80 +0.30% 664,684
26-09-24 GBX 67.60 +0.75% 799,772
26-09-23 GBX 67.10 -1.32% 568,820
26-09-22 GBX 68.00 -0.73% 945,410
26-09-21 GBX 68.50 +1.78% 2,099,708
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
6
Last Close Price
0.6780GBP
Average target price
0.9850GBP
Spread / Average Target
+45.28%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. DOCS Stock